Nova Mentis Life Science Corp.

PNK:NMLSF

$0.0277 USD

$0.02 (793.55%)

Volume
2
Average Volume
4.82K
Market Capitalization
$4.11M
P/E Ratio
-1.18
Dividend Yield
0.00%
Price Target
$
Year High
$0.09
Year Low
$0.01
Payout Ratio
$0.00
Current Ratio
$0.02

Industry, Sector & symbol

Stock Exchange Other OTC
CEO Mr. Steve Loutskou
Industry Biotechnology
Sector Healthcare
Current Symbol NMLSF
CUSIP 66980V106
CIK 0001689231
Web https://www.novamentis.ca
Phone 778-819-0244
Currency USD
Employees None
Country CA

Liquidity

Debt-to-Equity Ratio -0.06
Payout Ratio 0.00
Current Ratio 0.02
Quick Ratio 0.02
Cash Ratio 0.01

Sales & Book Value

Annual Sales $25405
Price / Sales 0.00
Cash Flow 0.00
Price / Cash Flow -2.27
Price / Book -0.71

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.0083
Trailing P/E Ratio -1.18
PEG Ratio -0.05
P/E Growth -0.05
Net Income $-1.22M
Net Margin 0.00%
Pretax Margin 0.00%
Return on Equity 73.69%
Return on Assets -2385.69%

Financials Score

AltmanZ Score -3289.80
Piotroski Score 1.00
Working Capital -1.06M
Total Assets 26.35K
Ebit -648.34K
Market Cap 4.11M
Total Liabilities 1.07M

Poll Results

About Nova Mentis Life Science Corp. (PNK:NMLSF) Stock

Nova Mentis Life Science Corp., through its subsidiaries, engages in developing diagnostics and psilocybin based therapeutics for neuroinflammatory conditions with a focus on autism spectrum disorder and fragile X syndrome in Canada. It is also involved in the research and development of anti-inflammatory effects of psilocybin for metabolic indications, such as obesity and diabetes; and development of cannabis products. Nova Mentis Life Science Corp. has a research agreement with the University of Central Florida (UCF) to develop a saliva serotonin assay. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada. ...

Nova Mentis Assigns Intellectual Property

2024-08-27 09:00:00

Vancouver, British Columbia--(Newsfile Corp. - August 27, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company") is pleased to announce it has entered into an intellectual property conveyance agreement (the "Agreement") with Ludwig Enterprises Inc. ("LUDG") and Dr. Marvin S. Hausman ("Hausman"), CEO of Ludwig, pursuant to which the Company shall assign to Ludwig all of its intellectual property and patent of the mRNA Neuro Panel and Serotonin Assay, along with any and all data accumulated testing these assays (the "Property").

CSE Bulletin: WITHDRAWN - Symbol Change - Inactive Designation - Nova Mentis Life Science Corp. (NOVA)

2024-08-08 15:27:00

Toronto, Ontario--(Newsfile Corp. - le 8 août/August 2024) - Bulletin 2024-0809 - Symbol Change - Inactive Designation - Nova Mentis Life Science Corp. (NOVA) has been withdrawn. If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: [email protected] Si vous avez des questions ou si vous avez besoin d'informations supplémentaires, veuillez contacter le service des inscriptions au 416 367-7340 ou par courriel l'adresse: [email protected]

CSE Bulletin: Symbol Change - Inactive Designation - Nova Mentis Life Science Corp. (NOVA)

2024-08-08 12:54:00

Toronto, Ontario--(Newsfile Corp. - Le 8 août/August 2024) - The Exchange has determined that Nova Mentis Life Science Corp. (the “Issuer”) has not met the continued listing requirements as set out in CSE Policy 2, Appendix A, section 2A.6. Pursuant to Policy 3 section 3.5(2), the Issuer may not rely on confidential price protection, nor may the Issuer complete any financing without prior Exchange approval.

Nova Mentis Announces Change of Directors

2024-02-26 08:30:00

Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company") announces the appointment of Steve Loutskou to the Company's Board of Directors, effective February 23, 2024. Mr. Loutskou, a seasoned serial entrepreneur, boasts a career spanning over 20 years, marked by numerous success stories.

Nova Mentis Applauds Government Decision to Create Rare Disease Advisory Group

2023-11-03 08:30:00

Vancouver, British Columbia--(Newsfile Corp. - November 3, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is pleased the Canadian government has established a new Implementation Advisory Group (IAG) for drugs for rare diseases, as part of its National Strategy to help facilitate information sharing and improve access and affordability of effective drugs for rare diseases across the country. As part of this overall investment, the Government of Canada will make available up to $1.4 billion to provinces and territories through bilateral agreements.

Frequently Asked Questions

What is the current Nova Mentis Life Science Corp. (NMLSF) stock price?

Nova Mentis Life Science Corp.(PNK:NMLSF) stock price is $0.0277 in the last trading session. During the trading session, NMLSF stock reached the peak price of $0.109 while $0.0064 was the lowest point it dropped to. The percentage change in NMLSF stock occurred in the recent session was 793.55% while the dollar amount for the price change in NMLSF stock was $0.02.

NMLSF's industry and sector of operation?

The PNK listed NMLSF is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of NMLSF?

Mr. Steve Loutskou | President, Chief Executive Officer & Director
Ms. Kelly Pladson | Corporate Secretary
Ms. Rebecca Lynn Hudson C.A., CPA | Chief Financial Officer
Mr. Derek Lloyd Harry Ivany | Executive Chairman
Dr. Aylia Mohammadi B.Sc., M.Sc., Ph.D. | President & Chief Scientific Officer of Nova Mentis Biotech Corporation

How many employees does NMLSF have?

Number of NMLSF employees currently stands at None. NMLSF operates from 700-838 West Hasting Street, Vancouver, BC V6C 0A6, CA.

Link for NMLSF official website?

Official Website of NMLSF is: https://www.novamentis.ca

How do I contact NMLSF?

NMLSF could be contacted at phone #778-819-0244 and can also be accessed through its website. NMLSF operates from 700-838 West Hasting Street, Vancouver, BC V6C 0A6, CA.

How many shares of NMLSF are traded daily?

The average number of NMLSF shares traded daily for last 3 months was 4.82K.

What is the market cap of NMLSF currently?

The market value of NMLSF currently stands at $4.11M with its latest stock price at $0.0277